Haemodynamic-guided and device-free shunting for heart failure with preserved ejection fraction.
作者信息
Reddy Yogesh N V, Miranda William R
机构信息
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Heart. 2025 Jun 19. doi: 10.1136/heartjnl-2025-326328.
Abstract
摘要
相似文献
1
Haemodynamic-guided and device-free shunting for heart failure with preserved ejection fraction.射血分数保留的心力衰竭的血流动力学引导及无装置分流术
Heart. 2025 Jun 19. doi: 10.1136/heartjnl-2025-326328.
2
Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.脉压、主动脉瓣峰值速度与心肌梗死后心力衰竭的发生：一项队列研究
Heart. 2025 Mar 26;111(8):370-377. doi: 10.1136/heartjnl-2024-324517.
3
Clinical outcomes and cardiovascular responses to exercise training in heart failure patients with preserved ejection fraction: a systematic review and meta-analysis.射血分数保留的心力衰竭患者运动训练的临床结局和心血管反应：一项系统评价和荟萃分析。
J Appl Physiol (1985). 2015 Sep 15;119(6):726-33. doi: 10.1152/japplphysiol.00904.2014. Epub 2015 Mar 6.
4
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
5
Exercise training in heart failure patients with preserved ejection fraction: a systematic review and meta-analysis.射血分数保留的心力衰竭患者的运动训练：一项系统评价和荟萃分析。
Monaldi Arch Chest Dis. 2016 Oct 14;86(1-2):759. doi: 10.4081/monaldi.2016.759.
6
Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.药物治疗对射血分数保留的心力衰竭结局的影响：系统评价和荟萃分析。
Heart. 2018 Mar;104(5):407-415. doi: 10.1136/heartjnl-2017-311652. Epub 2017 Aug 5.
7
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.心力衰竭伴射血分数保留与药物超适应证联用的相关性研究。
Circ Heart Fail. 2021 Nov;14(11):e008293. doi: 10.1161/CIRCHEARTFAILURE.120.008293. Epub 2021 Oct 22.
8
The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.生长分化因子 15、半乳糖凝集素 3 和可溶性 ST2 作为心力衰竭保留射血分数和心力衰竭射血分数降低的诊断生物标志物的效用：系统评价。
Heart Fail Rev. 2021 Jul;26(4):799-812. doi: 10.1007/s10741-020-09913-3.
10
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.慢性阻塞性肺疾病对射血分数保留心力衰竭患者的影响：PARAGON-HF 研究的启示。
J Am Heart Assoc. 2021 Dec 7;10(23):e021494. doi: 10.1161/JAHA.121.021494. Epub 2021 Nov 19.
本文引用的文献
1
Left atrial pressure normalisation by graded radiofrequency atrial septostomy in heart failure with preserved ejection fraction: a single-arm pilot study.通过分级射频房间隔造口术使射血分数保留的心力衰竭患者左心房压力正常化：一项单臂前瞻性研究。
Heart. 2025 May 27. doi: 10.1136/heartjnl-2025-325929.
2
Atrial Shunt Therapy for Heart Failure: An Update.心力衰竭的心房分流治疗：最新进展
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101203. doi: 10.1016/j.jscai.2023.101203. eCollection 2023 Nov-Dec.
3
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.达格列净对射血分数保留的心力衰竭的心脏和代谢影响：CAMEO-DAPA 试验。
Circulation. 2023 Sep 5;148(10):834-844. doi: 10.1161/CIRCULATIONAHA.123.065134. Epub 2023 Aug 3.
4
The RAISE Trial: A Novel Device and First-in-Man Trial.RAISE 试验：一种新型装置和首例人体试验。
Circ Heart Fail. 2022 Apr;15(4):e008362. doi: 10.1161/CIRCHEARTFAILURE.121.008362. Epub 2022 Apr 5.
5
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.用于射血分数保留和轻度降低的心力衰竭的心房分流装置（REDUCE LAP-HF II）：一项随机、多中心、双盲、假对照试验。
Lancet. 2022 Mar 19;399(10330):1130-1140. doi: 10.1016/S0140-6736(22)00016-2. Epub 2022 Feb 1.
6
Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.房间隔分流对射血分数保留心力衰竭患者肺血管功能的影响。
J Am Coll Cardiol. 2019 Nov 26;74(21):2539-2550. doi: 10.1016/j.jacc.2019.08.1062.
7
The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者运动时肺充血的血液动力学基础。
Eur Heart J. 2019 Dec 1;40(45):3721-3730. doi: 10.1093/eurheartj/ehz713.
8
Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者的血液动力学、呼吸困难和肺储备。
Eur Heart J. 2018 Aug 7;39(30):2810-2821. doi: 10.1093/eurheartj/ehy268.
Zotero 插件